Good health starts with knowing the right place to turn when choosing a medical laboratory to process your test results. Welcome to 911 Labs, designed to provide you with the highest caliber of test results delivered by a licensed staff of medical professionals. Delivered expediently, with utmost accuracy and outstanding customer care. Designed to meet all of your laboratory needs while geared to serve a wide range, from allied healthcare professionals to the individual person at home.
We understand it can be confusing to navigate all of this on your own. Our team is available to help answer all of your questions and get you on the path to full health!
• Accuracy – Our testing methods are considered “gold standard” for results, with 95% of instances correctly reported.
• Clinical Competency – We meet and exceed comprehensive guidelines from CDC and Association of Public Health Laboratories (APHL) to ensure delivery of quality, effective, efficient clinical outcomes, and improved patient health.
• Excellence – We will strive for greatness, in all tasks, regardless of the obstacles in the way
• Expeditious – Our services, complimented with technology platforms, allow timely delivery for improving the customer experience.
• Flexibility – We adapt our services according to the present community needs with a focus on adjusting to the health initiatives.
The vision of our business is to become the community leader in preventative testing services who is at the forefront in helping prevent the spread of disease, early detection, and treatment.
Committed to personalized, around-the-clock service, with rapid turnaround time. We provide expert interpretation and consultation for the best in patient care.
911 Labs offers a range of testing and high complexity lab services with results delivered on your phone, tablet or desktop – many within hours. We offer COVID PCR testing, Respiratory Panel PCR test (for common cold/flu-like illnesses) and mobile concierge COVID test results for individuals and film and television production studios.
IFU:
Accula SARS-CoV-2 Test – Instructions for Use
Fact Sheet:
Accula SARS-CoV-2 Test – Patient Fact Sheet
FAQ:
ACCULA™ TESTING INFORMATION & FREQUENTLY ASKED QUESTIONS (FAQ)
IFU:
Assure COVID-19 IgG/IgM Rapid Test Device – Instructions for Use
Fact Sheet:
Assure COVID-19 IgG/IgM Rapid Test Device – Recipient Fact Sheet
IFU:
https://bdveritor.bd.com/content/dam/bdveritor/pdfs/BD-Veritor-IFU.pdf
Fact Sheet:
BD Veritor System for Rapid Detection of SARS-CoV-2 & Flu A+B – Fact Sheet for Patients
IFU:
Fact Sheet:
FAQ:
IFU:
https://www.fda.gov/media/136112/download
Fact Sheet:
https://www.fda.gov/media/136114/download
FAQ:
https://assets.thermofisher.com/TFS-Assets/GSD/Reference-Materials/taqpath-covid-19-eua-faq.pdf
The TaqPath™ COVID-19 Combo assay is an in vitro real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate swabs, nasopharyngeal aspirates, and bronchoalveolar lavage (BAL) specimens from individuals suspected of COVID-19 by their healthcare provider. Results are for the identifications of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in upper respiratory and BAL specimens during the acute phase of infection.
Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Laboratories in the United States and its territories are required to report all test results to the appropriate public health authorities.
Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information.
Invalid results or inconclusive test results warrant repeat testing and clinical correlation, especially if COVID-19 exposure is suspected.
The TaqPath™ COVID-19 Combo assay has been authorized by the FDA under an Emergency Use Authorization (EUA) for use in authorized laboratories – laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meets requirements to perform high complexity tests.
All patient management decisions should be based on clinical judgment of a qualified health care professional.
These results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.
At 911 Labs, our team is made up of dedicated professionals with a passion for providing accurate and reliable medical testing. Our team includes experienced laboratory technicians, knowledgeable medical directors, and dedicated customer service representatives. We are committed to staying at the forefront of industry developments and utilizing the latest technologies to provide the best possible service to our clients. Whether you’re a patient looking for diagnostic testing or a healthcare provider in need of lab services, our team is here to support you every step of the way. Trust in 911 Labs for all of your medical testing needs.
